#Mirum Pharmaceuticals

Why a Top Holder Sold 115,000 Mirum Shares but Still Faces $185M Exposure

A major investor sold 115,000 Mirum shares but retains about $185M exposure—likely due to remaining equity, derivatives, or conversion rights rather than lost confidence.

Mirum Pharmaceuticals (MIRM) Hits New High and Enters a Buy Zone

Mirum Pharmaceuticals (MIRM) has topped previous highs and entered a buy zone. The rare-disease drugmaker's improving relative strength and pipeline progress make it notable.